کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5545897 1555643 2017 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Characterization and vaccine potential of Fasciola gigantica saposin-like protein 1 (SAP-1)
موضوعات مرتبط
علوم زیستی و بیوفناوری علوم کشاورزی و بیولوژیک علوم دامی و جانورشناسی
پیش نمایش صفحه اول مقاله
Characterization and vaccine potential of Fasciola gigantica saposin-like protein 1 (SAP-1)
چکیده انگلیسی


- FgSAP-1 protein was expressed at high level in caecal epithelium of early stages of F. gigantica.
- Recombinant saposin-like protein 1 (rFgSAP-1) exhibited vaccine potential against F. gigantica infection in mice.
- Vaccination with rFgSAP-1 showed high levels of protection at 73.2-74.3%.
- Vaccination with rFgSAP-1 reduced the pathological lesions of livers.
- Vaccination with rFgSAP-1 showed a mixed Th1/Th2 response with Th2 predominating.

The recombinant Fasciola gigantica Saposin-like protien-1 (rFgSAP-1) was cloned by polymerase chain reaction (PCR) from NEJ cDNA, expressed in Escherichia coli BL21 (DE3) and used for production of a polyclonal antibody in rabbits (anti-rFgSAP-1). By immunoblotting and immunohistochemistry, rabbit IgG anti-rFgSAP-1 reacted with rFgSAP-1 at a molecular weight 12 kDa, but not with rFgSAP-2. The rFgSAP-1 reacted with antisera from mouse infected with F. gigantica metacercariae collected at 2, 4, and 6 weeks after infection. The FgSAP-1 protein was expressed at a high level in the caecal epithelium of metacercariae and NEJs. The vaccination was performed in Imprinting Control Region (ICR) mice (n = 10) by subcutaneous injection with 50 μg of rFgSAP-1 combined with Alum adjuvant. Two weeks after the second boost, mice were infected with 15 metacercariae per mouse by the oral route. The percents protection of rFgSAP-1 vaccine were estimated to be 73.2% and 74.3% when compared with non vaccinated-infected and adjuvant-infected controls, respectively. The levels of IgG1 and IgG2a specific to rFgSAP-1 in the immune sera, which are indicative of Th2 and Th1 immune responses, were inversely and significantly correlated with the numbers of worm recoveries. The rFgSAP-1-vaccinated mice showed significantly reduced levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and liver damage. These indicated that rFgSAP-1 has strong potential as a vaccine candidate against F. gigantica, whose efficacy will be studied further in large economic animals including cattle, sheep, and goat.

155

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Veterinary Parasitology - Volume 233, 15 January 2017, Pages 115-122
نویسندگان
, , , , , , ,